<DOC>
	<DOCNO>NCT00097539</DOCNO>
	<brief_summary>The purpose multicenter , open-label , observational , post-marketing surveillance study collect long term safety efficacy information growth hormone ( GH ) product : Protropin ( somatrem injection ) , Nutropin ( somatropin injection ) , Nutropin AQ ( somatropin injection ) , Nutropin Depot ( somatropin injectable suspension ) treatment pediatric growth disorder GH prescribe .</brief_summary>
	<brief_title>National Cooperative Growth Study ( NCGS ) : A Post-marketing Surveillance Program Nutropin , Nutropin AQ , Nutropin Depot , Protropin</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Participants open epiphyses Children either sex treat Nutropin Depot , Nutropin AQ , Nutropin , Protropin treatment growth failure Participants willing keep follow appointment throughout study participation Participants treat nonGenentech GH preparation Participants close epiphysis Participants active neoplasia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pediatric growth disorder</keyword>
</DOC>